SCHEMBL29823902

SCHEMBL29823902

CC(c1ccccc1)N(Cc1cccc(CNCc2ccccn2)c1)Cc1ccccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.50
KMT2A Q03164 6/20 0.50
ALDH1A1 P00352 3/20 0.50
KDM4E B2RXH2 3/20 0.44
L3MBTL1 Q9Y468 5/20 0.43
SMARCA2 P51531 1/20 0.42
CYP2D6 P10635 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
CCR5 P51681 1/20 0.39
TP53 P04637 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1878739 1.00 MEN1 (0.50) MEN1KMT2AALDH1A1KDM4EL3MBTL1
SCHEMBL1874025 0.81 ALDH1A1 (0.44) MEN1KMT2AALDH1A1KDM4EL3MBTL1
SCHEMBL1881875 0.79 ALDH1A1 (0.43) MEN1KMT2AALDH1A1KDM4EL3MBTL1
SCHEMBL30225577 0.78 KMT2A (0.68) MEN1KMT2AALDH1A1KDM4EL3MBTL1
SCHEMBL14931741 0.78 KMT2A (0.68) MEN1KMT2AALDH1A1KDM4EL3MBTL1
SCHEMBL14025550 0.76 ALDH1A1 (0.48) MEN1KMT2AALDH1A1KDM4EL3MBTL1
SCHEMBL4428290 0.75 ALDH1A1 (0.53) MEN1KMT2AALDH1A1KDM4EL3MBTL1
SCHEMBL1876917 0.74 HPGD (0.40) MEN1KMT2AALDH1A1KDM4EL3MBTL1
SCHEMBL1874483 0.72 CYP2D6 (0.39) MEN1KMT2AALDH1A1KDM4EL3MBTL1
SCHEMBL22305532 0.72 ALDH1A1 (0.60) MEN1KMT2AALDH1A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308694-A1 DOSING REGIMENS FOR HEMATOPOIETIC STEM CELL MOBILIZATION FOR STEM CELL TRANSPLANTS IN MULTIPLE MYELOMA PATIENTS Magenta Therapeutics, Inc. (US) 2024-01-24 EP disclosed
CN-115997009-A Methods and compositions for in vivo transduction of hematopoietic stem and progenitor cells 美真达治疗公司 2023-04-21 CN disclosed
EP-4143302-A1 METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PROGENITOR CELLS IN VIVO Magenta Therapeutics, Inc. (US) 2023-03-08 EP disclosed
WO-2022197776-A1 DOSING REGIMENS FOR HEMATOPOIETIC STEM CELL MOBILIZATION FOR STEM CELL TRANSPLANTS IN MULTIPLE MYELOMA PATIENTS Magenta Therapeutics, Inc. (US) 2022-09-22 WO disclosed
EP-4051298-A1 DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENTOR CELLS Magenta Therapeutics, Inc. (US) 2022-09-07 EP disclosed